Looking for our Business Solutions? Click here:CloudQuote APIsContact Us

Vivakor, Inc. - Common Stock (VIVK)

0.2250
-0.0099 (-4.21%)
NASDAQ · Last Trade: Nov 22nd, 5:06 PM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close0.2349
Open0.2265
Bid0.2149
Ask0.2229
Day's Range0.2000 - 0.2294
52 Week Range0.1918 - 9,300.00
Volume2,153,623
Market Cap2.26M
PE Ratio (TTM)0.0000
EPS (TTM)100,839.3
Dividend & YieldN/A (N/A)
1 Month Average Volume18,727,295

Chart

About Vivakor, Inc. - Common Stock (VIVK)

Vivakor is a technology-driven company focused on environmental sustainability and resource recovery. It specializes in refining and reclaiming valuable resources from waste materials, particularly in the energy sector, while also emphasizing eco-friendly practices. The company's innovative processes aim to transform waste into valuable products, contributing to both economic efficiency and environmental conservation. Through its operations, Vivakor strives to promote a circular economy by reducing landfill waste and sourcing energy in a more sustainable manner. Read More

News & Press Releases

US Session Top Movers: Gainers and Declinerschartmill.com
Via Chartmill · November 17, 2026
Small-Cap Stock Movers: Today's Top Gainers and Loserschartmill.com
Via Chartmill · November 17, 2026
Gap Stocks: Gapping Up and Down in Today's US Sessionchartmill.com
Via Chartmill · November 17, 2026
Premarket Movers: Low-Priced Stocks Swing Before Nov. 17, 2026 Openchartmill.com
Via Chartmill · November 17, 2026
After-Hours Market Movers: Microcaps and Small Caps Post Sharp Gains and Losseschartmill.com
Via Chartmill · November 16, 2026
Unusual Volume Leaders: OMH, PARA, CODX in Current Sessionchartmill.com
Via Chartmill · November 10, 2026
After-Hours Market Movers: Gainers and Decliners From Today's U.S. Sessionchartmill.com
Via Chartmill · November 6, 2026
Top US Stock Gainers and Losers in Today's Sessionchartmill.com
Via Chartmill · November 6, 2026
Top US Stock Gainers and Losers: Nov. 6, 2026 Sessionchartmill.com
Via Chartmill · November 6, 2026
Gap Stocks in Today's Sessionchartmill.com
Via Chartmill · November 6, 2026
Postmarket Movers: After-Hours Gainers and Loserschartmill.com
Via Chartmill · October 30, 2026
Top Stock Gainers and Losers in Today's Sessionchartmill.com
Via Chartmill · October 30, 2026
Top Movers for Oct. 30, 2026: CHOW Leads Gainers, JDZG Leads Loserschartmill.com
Via Chartmill · October 30, 2026
Gap-Up and Gap-Down Stocks for October 30, 2026chartmill.com
Via Chartmill · October 30, 2026
Monday's session: top gainers and loserschartmill.com
Via Chartmill · October 12, 2026
What's going on in today's sessionchartmill.com
Via Chartmill · October 12, 2026
These stocks are gapping in today's sessionchartmill.com
Via Chartmill · October 12, 2026
These stocks are moving in today's pre-market sessionchartmill.com
Via Chartmill · October 12, 2026
Gapping stocks in Friday's sessionchartmill.com
Via Chartmill · October 9, 2026
Which stocks are experiencing notable movement on Thursday?chartmill.com
Via Chartmill · October 1, 2026
Thursday's session: gap up and gap down stockschartmill.com
Via Chartmill · October 1, 2026
These stocks that are showing activity before the opening bell on Thursday.chartmill.com
Via Chartmill · October 1, 2026
What's going on in today's after hours sessionchartmill.com
Via Chartmill · September 14, 2026
Peraso (NASDAQ: PRSO) Eyes Military Robotics as U.S. Army Advances Autonomous Fleet
September 2, 2026 - Peraso Inc. (NASDAQ: PRSO) could be positioned for an emerging opportunity across military robotics, autonomous systems and secure tactical communications as the U.S. Army advances its Infantry Last Tactical Mile initiative for robotic tactical resupply, casualty evacuation (CASEVAC) and network extension .
Via AB Newswire · September 2, 2026
VivoSim Labs (NASDAQ: VIVS) Opens New Pharma Opportunity
September 2, 2026 - VivoSim Labs, Inc. (NASDAQ: VIVS) is expanding the potential commercial reach of its NAMkind™ drug toxicology platform, announcing plans to develop a rat liver model that would complement its existing 3D human liver model and help pharmaceutical companies distinguish animal-specific toxicity from risks that may translate to humans.
Via AB Newswire · September 2, 2026